As of Oct 05
| -2.65 / -1.60%|
The 17 analysts offering 12-month price forecasts for Alexion Pharmaceuticals Inc have a median target of 223.00, with a high estimate of 257.00 and a low estimate of 186.00. The median estimate represents a +36.46% increase from the last price of 163.42.
The current consensus among 20 polled investment analysts is to Buy stock in Alexion Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.